Table 1.
Study parameters measured by study visits
| Study visits | V0 | V1 | V2 | V3 | V4 |
|---|---|---|---|---|---|
|
| |||||
| Time of visits | At inclusion | At 1 month | At 2 months | At 3 months | At 6 months |
|
| |||||
| Subjects attending visits | n=227 (100%) | n=132 (58.1%) | n=88 (38.8%) | n=65 (28.6%) | n=53 (23.3%) |
| Demographic information | |||||
| Age, mean±SD (n) | 45.5±13.6 (227) | ||||
| Sex (female), % (n) | 64.3 (227) | ||||
| Cigarette consumption, % | |||||
| 1–10 cig/d | 17 | ||||
| 11–22 cig/d | 56 | ||||
| 21–30 cig/d | 22 | ||||
| >30 cig/d | 5 | ||||
| At least one possible smoking-related illness, % | 75 | ||||
| Fagerström score (out of 10), mean±SD | 4.96±2.37 | ||||
| Motivation to quit smoking (VAS 0–10), mean±SD | 7.3±2.2 | ||||
| NRT users, % | 96.9 | 86.4 | 84.1 | 69.2 | 45.3 |
| Duration of the interview (minutes), mean±SD | n=222 | n=129 | n=83 | n=62 | n=49 |
| Average duration | 29.7±13.1 | 22.4±9.9 | 20.5±7.3 | 22.9±9.6 | 20.7±9.1 |
| Main topic selected for the interview, % | |||||
| Benefits of smoking cessation | 37.2 | 26.6 | |||
| Helping pregnant women to stop | 20.7 | ||||
| Perceived risks of quitting | 27.1 | 18.8 | |||
| Quality of life: SF-12, mean±SD | n=226 | n=130 | n=86 | n=64 | n=51 |
| Physical composite score | 49.1±9.6 | 50.7±9.0 | 51.9±7.5 | 51.4±8.4 | 53.54±7.8 |
| Mental composite score | 42.6±10.8 | 46.1±10.5 | 47.5±10.4 | 49.4±9.2 | 48.96±11.5 |
| SF-12 for the 53 completers, mean±SD | n=53 | n=49 | n=52 | n=49 | n=51 |
| Physical composite score | 48.0±10.3 | 51.4±9.8 | 52.0±8.4 | 52.0±8.2 | 53.5±7.8 |
| Mental composite score | 42.8±11.3 | 47.7±11.0 | 47.2±11.4 | 49.4±9.6 | 49.0±11.5 |
| SCQoL subscores, mean±SD | n=226 | n=130 | n=87 | n=64 | n=51 |
| Self-control | 39.3±17.5 | 51.4±18.9 | 53.5±19.6 | 58.2±18.3 | 59.2±17.4 |
| Anxiety | 51.8±26.2 | 61.4±24.5 | 66.2±24.9 | 71.9±22.6 | 69.1±21.9 |
| Social interactions | 40.5±11.2 | 43.2±11.02 | 45.8±11.2 | 46.5±9.8 | 45.8±13.8 |
| Sleep | 52.4±16.8 | 53.30±17.1 | 55.41±15.7 | 53.8±15.8 | 57.6±18.4 |
| Subject receptiveness (VAS 0–10), mean±SD | 8.4±2.0 | 8.6±1.8 | 8.8±1.7 | 8.6±2.4 | |
| Questionnaire on smoking cessation | |||||
| Number of cigarettes per day, mean±SD | 4.3±6.4 | 3.3±5.5 | 2.5±5.0 | 1.4±3.6 | |
| Weight gain since the last visit, % of yes | 33.6 | 45.5 | 40.0 | 49.1 | |
| Participant satisfaction (CSQ8), mean±SD | n=65 | n=53 | |||
| Global score (out of 4) | 3.6±0.4 | 3.7±0.4 | |||
| Pharmacist satisfaction (VAS 0=not at all, 10=very useful), mean±SD | n=20 | ||||
| “Is the STOP study useful to my pharmaceutical practice?” | 8.1±1.5 | ||||
| “Is the STOP study adapted to my pharmaceutical practice?” | 7.5±1.2 | ||||
| “Is the STOP study adapted to my clients?” | 7.1±1.2 | ||||
Abbreviations: VAS, visual analog scale; NRT, nicotine replacement therapy; SF-12, Short Form 12; SCQoL, Smoking Cessation Quality of Life; CSQ8, Client Satisfaction Questionnaire; STOP, Sevrage Tabagique à l’Officine: Smoking Cessation Program at the Pharmacy.